Etico was established by a team of seasoned professionals with a mission to develop and produce
innovative, high-quality medicines. As a US FDA-registered company (FEI No: 3013758337 & DUNS
No: 67-546-6037) with ISO 9001:2015 certification, DCA (Form 37) approval, and recognition as a GLP
and DSIR-certified research organization, we specialize in the development of generics, generic plus,
and controlled release products across multiple therapeutic areas and dosage forms.
Based in Hyderabad, we collaborate with leading national and international generic companies to
bring advanced development assets to market, ensuring our partners can deliver safe and effective
medications to millions of patients worldwide. Our goal is to be a comprehensive solution provider,
guiding clients from initial development through to successful product launch.
Our business strategy is centered on the development of niche generic and specialty pharmaceutical
products, tailored to meet the unique needs of our clients through a variety of business models. We
collaborate with leading drug developers and manufacturers, offering advanced development
solutions and capabilities that ensure the delivery of safe and effective medications. By aligning our
expertise with the specific requirements of our partners, we are able to bring innovative
pharmaceutical products to market, addressing critical needs in the healthcare industry.
